Oncoplastic level II volume displacement surgery for breast cancer: oncological and aesthetic outcomes.
Breast cancer
Breast-Q
Oncoplastic breast conserving surgery
Volume displacement
Journal
Updates in surgery
ISSN: 2038-3312
Titre abrégé: Updates Surg
Pays: Italy
ID NLM: 101539818
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
received:
07
07
2022
accepted:
20
02
2023
medline:
21
7
2023
pubmed:
3
3
2023
entrez:
2
3
2023
Statut:
ppublish
Résumé
Oncoplastic breast-conserving surgery (OBCS) is increasingly used to treat breast cancer with the dual purpose of performing a radical oncological resection while minimizing the risk of post-operative deformities. The aim of the study was to evaluate the patient outcomes after Level II OBCS as regards oncological safety and patient satisfaction. Between 2015 and 2020, a cohort of 109 women consecutively underwent treatment for breast cancer with bilateral oncoplastic breast-conserving volume displacement surgery; patient satisfaction was measured with BREAST-Q questionnaire. The 5-year overall survival and disease-free survival were 97% (95%CI 92, 100) and 94% (95%CI 90, 99), respectively. In two patients (1.8%), mastectomy was finally performed due to margin involvement. The median patient-reported score for "satisfaction with breast" (BREAST-Q) was 74/100. Factors associated with a lower aesthetic satisfaction index included: location of tumour in central quadrant (p = 0.007); triple negative breast cancer (p = 0.045), and re-intervention (p = 0.044). OBCS represents a valid option in terms of oncological outcomes for patients otherwise candidate to more extensive breast conserving surgery; the high satisfaction index also suggests a superiority in terms of aesthetic outcomes.
Identifiants
pubmed: 36862354
doi: 10.1007/s13304-023-01472-0
pii: 10.1007/s13304-023-01472-0
pmc: PMC10359384
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1289-1296Informations de copyright
© 2023. The Author(s).
Références
Arch Gynecol Obstet. 1987;241 Suppl:S11-9
pubmed: 3426257
Ann Surg Oncol. 2016 Oct;23(10):3247-58
pubmed: 27357177
Cochrane Database Syst Rev. 2021 Oct 29;10:CD013658
pubmed: 34713449
Langenbecks Arch Chir Suppl Kongressbd. 1997;114:1224-7
pubmed: 9574385
Ann Chir. 2006 Apr;131(4):256-61
pubmed: 16530156
J Breast Cancer. 2018 Sep;21(3):321-329
pubmed: 30275861
Breast Cancer Res Treat. 2016 Nov;160(1):79-89
pubmed: 27637781
Cancer Control. 2012 Oct;19(4):286-94
pubmed: 23037496
In Vivo. 2022 Mar-Apr;36(2):814-820
pubmed: 35241537
Breast. 2013 Aug;22 Suppl 2:S100-5
pubmed: 24074768
J Clin Oncol. 2020 Jul 10;38(20):2246-2253
pubmed: 32442070
Clin Breast Cancer. 2018 Aug;18(4):e595-e600
pubmed: 29731404
Plast Reconstr Surg. 2009 Aug;124(2):345-353
pubmed: 19644246
World J Surg Oncol. 2019 Jun 5;17(1):96
pubmed: 31167659
Ann Plast Surg. 2016 May;76 Suppl 3:S222-6
pubmed: 26808743
Nat Clin Pract Oncol. 2007 Nov;4(11):657-64
pubmed: 17965643
JAMA Surg. 2018 Oct 1;153(10):891-899
pubmed: 29926096
Eur J Surg Oncol. 2012 May;38(5):395-8
pubmed: 22436560
Ann Surg Oncol. 2010 May;17(5):1375-91
pubmed: 20140531
N Engl J Med. 2002 Oct 17;347(16):1233-41
pubmed: 12393820
Plast Reconstr Surg. 2010 Feb;125(2):454-462
pubmed: 20124831
Breast Cancer Res Treat. 2017 Aug;164(3):679-687
pubmed: 28536951
Breast J. 2021 Jan;27(1):35-43
pubmed: 33368761
Ann Plast Surg. 2007 Sep;59(3):235-42
pubmed: 17721207
Ann Surg. 2003 Jan;237(1):26-34
pubmed: 12496527
Breast Cancer Res Treat. 2017 Aug;165(1):139-149
pubmed: 28578506
Breast. 2014 Apr;23(2):104-11
pubmed: 24388734
Am J Surg. 2010 Aug;200(2):224-8
pubmed: 20573334
Surg Oncol. 2012 Jun;21(2):133-41
pubmed: 21411311
Ann Plast Surg. 1998 Nov;41(5):471-81
pubmed: 9827948
Eur J Surg Oncol. 2005 Oct;31(8):817-23
pubmed: 16043322
Surg Oncol. 2020 Dec;35:556-559
pubmed: 33220630
Ann Surg. 2019 Sep;270(3):473-483
pubmed: 31356276
Breast. 2017 Aug;34 Suppl 1:S78-S81
pubmed: 28690106
N Engl J Med. 2002 Oct 17;347(16):1227-32
pubmed: 12393819
Breast. 2021 Jun;57:25-35
pubmed: 33711697